This metabolic reprogramming suppresses antitumor immunity through three interconnected mechanisms: First, competitive glucose uptake by tumor cells and TAMs induces nutrient deprivation in TILs, suppressing mTOR activity and reducing effector cytokine secretion (e.g., IFN-γ, TNF-α) [207]. The gene discussed is MTOR; the disease is neoplasm.